Globus Medical Inc
GMED· NYSE
Released Feb 17, 2021, after the close
10-K filed Feb 17, 2021, 48 days after period end · 0001562762-21-000036
| Metric | Q4 2020 | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $233.45M | $211.67M | $195.94M | $176.03M |
| Net Income | $52.96M | $45.53M | $36.75M | $24.38M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.52 |
| $0.44 |
| $0.36 |
| $0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.